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Abstract: Antibiotic resistance refers to when microorganisms survive and grow in the presence
of specific antibiotics, a phenomenon mainly related to the indiscriminate widespread use and
abuse of antibiotics. In this framework, thanks to the design and fabrication of original functional
nanomaterials, nanotechnology offers a powerful weapon against several diseases such as cancer
and pathogenic illness. Smart nanomaterials, such as metallic nanoparticles and semiconductor
nanocrystals, enable the realization of novel drug-free medical therapies for fighting against
antibiotic-resistant bacteria. In the light of the latest developments, we highlight the outstanding
capabilities of several nanotechnology-inspired approaches to kill antibiotic-resistant bacteria.
Chemically functionalized silver and titanium dioxide nanoparticles have been employed for their
intrinsic toxicity, which enables them to exhibit an antimicrobial activity while, in a different
approach, photo-thermal properties of metallic nanoparticles have been theoretically studied and
experimentally tested against several temperature sensitive (mesophilic) bacteria. We also show that
it is possible to combine a highly localized targeting with a plasmonic-based heating therapy by
properly functionalizing nanoparticle surfaces with covalently linked antibodies. As a perspective,
the utilization of properly engineered and chemically functionalized nanomaterials opens a new
roads for realizing antibiotic free treatments against pathogens and related diseases.
Keywords: antibacterial agents; antibiotic resistance; gold nanoparticles; plasmonic resonance;
thermal inactivation
1. Antimicrobial Resistance
Chronic diseases and mortality are consequences of bacterial infections that represent a burden to
health and global economics. For their efficiency and effectiveness, antibiotics, exploited as antimicrobial
agents, represent a primary treatment method; however, since the first time they were released into
the environment, their successful use has been compromised by the development of tolerance and/or
resistance. Currently, multidrug resistance (MDR), related to the indiscriminate widespread use and
abuse of antibiotics has become, in fact, a serious global health problem, with devastating consequences
for patient care [1].
The number of MDR bacterial strains has increased significantly and, although many financial
resources have been invested, MDR has become faster than the development of new classes of antibiotic
molecules. This problem has not only clinical but also economic implications, as reported in a recent
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study [2] where authors estimate the health burden caused in EU and European Economic Area
(EEA) in 2015 by antibiotic-resistant bacteria. The study measured the impact of the phenomenon in
terms of number of cases, number of attributable deaths and disability-adjusted life years (DALYs),
calculated as the sum of “Years of Life Lost” and “Years of Life lived with Disability”. Eight
bacterial species frequently isolated from blood or cerebrospinal fluid have been included in this
study: Acinetobacter spp.; Enterococcus faecalis and faecium; Escherichia coli; Klebsiella pneumoniae;
Pseudomonas aeruginosa; Staphylococcus aureus meticillin-resistant (MRSA) and Streptococcus pneumoniae.
Results showed that 67.9% of DALYs were caused by infections with E. coli and K. pneumoniae
(resistant to cephalosporins of third-generation), S. aureus (methicillin-resistant) and P. aeruginosa
(carbapenem-resistant); bacteria resistant to carbapenems or colistin are responsible for 38.7% of
DALYs. Authors showed also that every age is involved in infections, significantly in childhood.
In adults, the burden increases with age, suggesting that the overall ageing of population in EU and
EEA entails a worsening of the problem. Figure 1a shows the number of attributable deaths, in 2015,
as a function of the number of cases in EU and European Economic Area for each bacterial species
under analysis. Diameter of bubbles represents DALYs. From data reported in Table 1 of that study [2],
we inferred Figure 1b, which shows the association between the number of cases in EU and European
Economic Area in 2015 and the percentage of deaths for each antibiotic-resistant bacteria. Figure 1a,b
show that the effect on health of antibiotic-resistant bacteria is related not only to virulent infections
with large incidences, and therefore large DALYs values, (bubbles diameters in Figure 1a), but also
to low incidence infections like carbapenem-resistant K. pneumoniae, a case where the percentage of
attributable mortality may result very high (see Figure 1b).
Figure 1. Infections with antibiotic-resistant bacteria, EU and European Economic Area, 2015. (a) The
diameter of bubbles represents the number of disability-adjusted life-years [2]. (b) Each blue point
represents antibiotic-resistant bacteria in EU and European Economic Area in 2015. Incidence cases are
reported on the x-axis, the relative percentage of attributable deaths is reported on the y-axis. Bacteria
are the same as in (a). ColRACI = colistin-resistant Acinetobacter spp. CRACI = carbapenem-resistant
Acinetobacter spp. MDRACI = multidrug-resistant Acinetobacter spp. VRE = vancomycin-resistant Enterococcus
faecalis and Enterococcus faecium. ColREC = colistin-resistant Escherichia coli. CREC = carbapenem-resistant
E. coli. 3GCREC = third-generation cephalosporin-resistant E. coli. ColRKP = colistin-resistant Klebsiella
pneumoniae. CRKP = carbapenem-resistant K pneumoniae. 3GCRKP = third-generation cephalosporin-resistant
K pneumoniae. ColRPA = colistin-resistant Pseudomonas aeruginosa. CRPA = carbapenem-resistant P aeruginosa.
MDRPA = multidrug-resistant P aeruginosa. MRSA = meticillin-resistant Staphylococcus aureus. PRSP =
penicillin-resistant Streptococcus pneumoniae. PMRSP = penicillin-resistant and macrolide-resistant S pneumoniae
Reprinted with permission from [2].
In order to understand how MDR develops, we have to recall the functioning mechanism
of antibiotics, which interact with their molecular targets to modify or block the normal bacteria
functions by exploiting different action. One of the principal antibacterial actions is the inhibition or
regulation of the enzymes involved in cell wall biosynthesis, as β-lactams antibiotics and glycopeptides
do. Antibiotics can also interfere with cell biochemical reactions (protein synthesis, macrolide,
metabolites), such as the folic acid, sulfonamides, and the nucleic acid synthesis do. On the other hand,
microorganisms show different alternatives to avoid the action of antibiotics, like the production of
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inactivating antibiotic enzymes, such as β-lactamase, alteration of the permeability of the envelope,
alteration of the target site, alternative metabolic pathways, biofilm formation [3]. As a matter of fact,
antimicrobial resistance to antibiotics is an ancient phenomenon occurring in the environment as a
passage of the evolutionary process [4] and represents not only a natural consequence of antibiotic
use, but also an intrinsic capacity of bacteria to survive in a hostile environment, due to their genetic
plasticity [5]. Furthermore, in addition to their intrinsic and adaptive [6] resistance to a particular
antimicrobial agent as a consequence of structural or functional characteristics, and to silent mutations,
bacteria have evolved sophisticated mechanisms to acquire, transfer and spread resistance genes.
The horizontal transfer of genes (HGT) is mediated, classically, by three main mechanisms [7]:
generalized, specialized and lateral transduction (phage mediated) [8]; transformation (transfer of
nacked DNA); conjugation (transfer by direct cell-to-cell contact) [9]. The emergence of resistance to
different types of drug (MDR) in the same bacterial cell allowed to identify mobile genetic elements,
transposons and integrons [10], whose special role is to develope and spread MDR among bacteria of
clinical relevance.
It is now acknowledged that most of microorganisms grow in the form of biofilms. More than
80% of all microbial infections are biofilm-related, as shown by the group of bacteria that form biofilms
called ESKAPE (Enterococcus faecalis, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii,
P. aeruginosa and Enterobacter spp.), responsible for high mortality [11]. Biofilms are made of
well-structured aggregations of single or multi-species bacteria, which cooperate with each other
and their environment, within polymeric matrices produced by cells themselves and attached to
biological surfaces or inerts. They have different morphologies depending on the bacterial strains and
growth conditions and are responsible for virulent and chronic infections. The classic developmental
model of biofilm formation consists of several distinct phases. In a first stage, single cells associate
with a solid surface by adhesion; then, in the second stage, they aggregate in micro colonies, usually
composed of many types of micro-communities, surrounded by self-produced extracellular polymeric
substance (EPS), such as proteins (<1–2%) including enzymes), DNA (<1%), polysaccharides (1–2%)
and RNA (<1%). In addition to these components, water (up to 97%) is the major part of biofilms and
is responsible for the flow of nutrients inside the biofilm matrix. In the final stage, a detachment from
mature biofilm (as planktonic bacteria) in the environment may occur; sometimes, a mechanical stress
may also be involved in this process [12].
Actually, bacterial biofilms exhibit an enhanced resistance to drug therapies and chemical
disinfection, and are more resistant to the immune system. This increased resistance is caused by many
factors: polymeric matrices protect cells and, as a result, antimicrobial drugs can hardly penetrate
the biofilm; concentration gradients of oxygen and nutrients in the biofilm lead to cell differentiation;
metabolic cooperation may cause expression of different antibiotic resistance genes that allow bacteria
to resist to the presence of high concentrations [13] of antimicrobial.
2. Nanomaterials as Antibacterial Agents
The term nanomaterials is used to indicate substances made of objects (nanoparticles NPs) where at
least one dimension is less than 100 nm. At this scale, they exhibit unique optical, magnetic and electrical
properties (different from the bulk material) that have great impact in many fields. The combination of
nanotechnology and biology opens new opportunities in biological and nanomedicine applications and
offers a potential solution to biological problems such as infection control and instrument sterilization.
They may have a strong catalytic activity, high toxicity and can be exploited for novel applications when
properties of atomic or bulk materials are unsuitable.
Many nanomaterials exhibit antimicrobial properties and for this reason they may be used to
control microbial populations [14–16]. Bacteria are essential to biodiversity on earth, but, as reported
in the introduction (Section 1), they are also cause of lethal infections for the human being. They can
be exposed to NPs in their natural environment without any adverse effect; for example, the flora
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of the skin can be exposed to large quantities of NPs incorporated into topical preparations and
cosmetics [17–22].
The formation of reactive oxygen species (ROS) leading to cell membrane, protein and DNA damage.
NPs intracellular localization has effects on cell reproduction and development, on DNA and it may
interfere with the pumping activity of the protein; moreover it causes an increase in cell permeability
and an uncontrolled transport through the cytoplasmic membrane and, ultimately, cell death. Ag+ leads
inhibition of the electron transport.
On the other hand, anti-bacterial NPs have been synthesized from metals, like gold [23], silver [24]
copper [25] and iron [26], and from oxides, like cerium oxide [27], zinc oxide [28], titanium dioxide [29]
and silicon dioxide [30]. In particular, gold nanoparticles (GNPs) are relatively inert but they become
toxic if coated with ligands such as ionic surfactants or antibiotics, which give them antibacterial
proprieties [23,31].
As a matter of fact, many studies of bionanotechnology are focused on medical applications,
where NPs can be used as anti-bacterials, either independently or in combination with other treatments.
A synergistic toxic effect of silver nanoparticles (AgNPs) and antibiotics was observed when tested
against E. coli. Originally this was reported for amoxicillin [32]; later on, the observation was extended
to include enhancement of effects of penicillin, erythromycin, clindamycin and vancomycin [33];
the study reported similar effects against S. aureus. Interestingly, both organisms frequently exhibit
antibiotic resistance [34]. The effect is not restricted to silver. Zinc oxide NPs increase the efficacy of
ciprofloxacin against E. coli [28]. Vancomycin, conjugated directly to the surface of GNPs, has more
efficient activity compared to vancomycin alone; in this case, the observed synergistic effects occur
because of an enhanced reactivity of molecules located at the GNPs surface.
NPs can also have effects in an indirect way, when bacteria must respond to challenging nutrient
limitation. Ag and TiO2 NPs proved to be toxic to bacteria in NPs coated surgical masks [29]; AgNPs
are active in water purification filters [35]; Experiment with E. coli show that AgNPs can cause cell
lysis and cell shrinking [36], with a significant inhibition of the cell growth. A recent hypothesis
on the action of silver NPs is that their degree of toxicity is proportional to the release of Ag+ [24],
an antimicrobial cation. AgNPs can also produce free radicals [37], with a diminished activity in
presence of an anti-oxidant. Redox-active NPs of iron, or composite NPs containig ferrous iron (Fe2+),
inhibit E. coli growth on solid medium [26]. Also TiO2, SiO2 and ZnO NPs exhibit an oxidative,
stress-based, toxic effect [30].
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3. Theoretical Description of Induced Temperature Variations
The study of the interaction of light with nanosized objects represents an important issue not only
for photonics and plasmonics but also for physics, chemistry, biology and nanomedicine. In application
areas, metallic NPs are of high interest because they possess an intrinsic ability to confine light
at the nanoscale through the excitation of Localized Plasmonic Resonance (LPR), a phenomenon
related to the formation of plasmons, that are oscillations of the free electrons localized at the
metal/dielectric interface. Under a resonant light illumination, metallic nanoparticles (MNPs) convert
light into heat, thus, becoming nanosources of heat, a phenomenon that opens up an unpredictable
number of applications, ranging from photonics to nanomedicine [38,39]. The effect is due to the
absorption associated to LPR formation, which triggers a heat generation process; this involves not
only absorption of incident photons, but also heat transfer from MNPs to the surrounding medium.
In this framework, Gold nanoparticles (GNPs) have gained an important role because their LPR
can be tuned from the visible to the near-infrared (NIR) range by simply changing their size, shape,
or the dielectric function of the surrounding medium. Moreover, GNPs are bio-compatible and can be
easily functionalized with a large variety of molecules, also exhibiting a weak oxidation. Thanks to
their properties, GNPs have been widely exploited in cancer therapy [40–44], ophthalmology and
dermatology, nanosurgery [45–49], photothermal imaging [50], plasmon-assisted nanochemistry [51],
plasmon-assisted optofluidics [52] and sensing [53,54].
Under the action of an impinging, resonant, electric field, due to the LPR onset, a single MNP
produces heat by Joule effect (see Figure 2); thus, in order to describe its temperature variation, it is
necessary to known its electric response function, that is its polarizability α. This appears in the
relation between the dipole moment p induced in the MNP and the electric field E of the impinging
electromagnetic wave:
p = αE (1)
α depends on shape, structure and nature of the surrounding medium as well as on the metal that the
MNP is made of.
Figure 2. Sphere, ellipse and a complex structure of metal nanoparticles. Temperature variation around
the MNP can be described through polarizability α, a parameter that depends on shape, structure and
metal that the MNP is made of (dielectric permittivity εNP and thermal conductivity kNP) as well as on
the surrounding medium (dielectric permittivity εm and thermal conductivity km).
The conversion efficiency of electromagnetic energy into heat depends on the MNP dimension
and, for small nanoparticles, can reach values as high as 100%. In the absence of phase transitions, if α
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is known, it is possible to predict the value of temperature around a MNP by solving the heat transfer
equation (Equation (2)), which derives from a heat energy balance: the net rate of thermal energy that
comes out from the MNP, plus the rate of thermal energy accumulation (internal energy variation in
the MNP) must equal the net rate of thermal energy generation:
∇ · (−k(r)∇T(r, t)) + ρ(r)c(r)∂T(r, t)
∂t
= Q(r, t) (2)
where r and t are the spatial and time coordinates, T (r, t) is the local temperature and parameters
k(r), ρ(r), c(r) indicate thermal conductivity, mass density and specific heat, respectively. The function
Q(r, t) represents the source of energy density, coming from the energy dissipation inside the MNP.
At the thermal equilibrium, solution of the Equation (2) is obtained by taking into account that heat
production takes place at a constant rate per unit time and per unit volume [55]. Calculations, carried
out in spherical coordinates, yield a temperature variation at a distance r from the MNP given by:
∆T =
q
4πKmr
(3)
where Km is the thermal conductivity of the surrounding medium and the thermal energy generation q
is given by
q = QVNP =< J(r, t) · E(r, t) >t VNP = σabs I = K=m(α)I (4)
where VNP is the total volume of the MNP, σabs is the absorption cross section of the MNP, K is the
wavevector of the impinging light of intensity I, < J(r, t) · E(r, t) >t is the energy converted into heat
due to joule effect into the metal (< ... >t indicates the time average and =m(α) is the imaginary
part of α). Equation (4) tells us that, if laser wavelength and intensity and structure polarizability are
known, it is possible to calculate thermal energy generation. In order to obtain the polarizability of
small MNPs (smaller than the wavelength), it is necessary to solve the Laplace equation by imposing
regularity condition in r = 0, reconnection to external field in r → ∞ and tangential and normal
continuity of the electric field (E) and electric displacement (D) at the interfaces. For spherical and
rod-like shapes (see Figure 2), it is possible to obtain an analytical expression for the polarizability α
whereas for complex structures like nano-matryoshkas or onion-like structure it is necessary to resort
to a numerical calculation. In spherical coordinates, polarizability α [56] is given by
αsphere = 3εmVNP
εNP − εm
εNP + 2εm
. (5)
where VNP is the total MNP volume, εNP is MNP permittivity, εm is the host medium permittivity.
Equation (5) shows that the resonance of α depends on the dielectric permittivity of the surrounding
medium εm through the Fröhlich condition involving the real part of εNP: <[εNP] = −2εm.
The polarizability of a metal nanorod can be calculated by using a prolate spheroid coordinate in
the dipole approximation [57], which yields α⊥ and α‖:
α⊥,‖ = 3εmVNP
εNP − εm
3εm + 3L⊥,‖(εNP − εm)
(6)
where⊥ and ‖ indicates if the direction of light polarization is perpendicular or parallel to the nanorod
long axis; L⊥,‖ are geometrical factors given by:
L‖ =
1− e2
e2
(
− 1 + 1
2e
ln
1 + e
1− e
)
L⊥ =
1− L‖
2
(7)
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e is the eccentricity (e2 = 1− 1/ρ where ρ is the aspect ratio of the spheroid ratio between long axis
and short axis).
Calculation of the polarizability of nano-matryoshkas like or onion like nanostructures [58], due to
the presence of many interfaces, requires to solve an equation system; if the structure symmetry is
known, the best way to calculate the polarizability is to use a numerical approach.
In order to provide a possibility of comparison, we report in Figure 3 the absorption cross section
σabs of four MNPs surrounded by water, with the same total volume, but different shapes and/or
structures: a gold nano sphere with radius Rnp = 10 nm, a gold nanorod with the same total volume
(16 nm and ∼7.9 nm for long and short axis respectively), a nano-shell made of a silica-core (with
radius 7 nm and a gold shell of 3 nm), and a multi-shell structure (onion-like) with total radius 10 nm
obtained by starting from a dielectric core and alternating gold/dielectric shells.
Figure 3. Curves represent the absorption cross section of four MNPs with the same total volume
and immersed in water: purple line for a gold nano-sphere with radius 10 nm, green line for a gold
nano-rod with long axis 16 nm and short axis ∼7.9 nm, blue line for a nano-shell made of a silica core
(radius 7 nm) and a gold shell of 3 nm, Yellow line for a multi-shell structure obtained starting from
a dielectric core and alternating gold/dielectric shell with total radius 10 nm.
Curves of Figure 3 show a plasmonic peak at different wavelength: λpeak = 520 nm for the sphere,
λpeak = 865 nm for the rod, λpeak = 580 nm for the nano-shell and two peaks for the multi-shell
λpeak,1 = 576 nm and λpeak,2 = 803 nm. The position of the plasmonic peak of the absorption cross
section σabs provides information on the best working wavelength and on the produced heat. Indeed,
by starting from the value of σabs at a particular working wavelength, it is possible to calculate the
localized temperature around the MNP (see Figure 2 and Equation (4)). By changing size, metal,
structure and surrounding medium (dielectric permittivity εm and thermal conductivity km) it is
possible to change the temperature around MNPs [56,59].
It is important to take into account that the effective temperature depends on the number of
MNPs acted on by the electromagnetic wave, because each MNP contributes to the heating process
through a heat transfer to the surrounding medium. Therefore the temperature will depend on the
arrangement (in a line, a surface or a bulk) and on the MNP density [59].
The heating process so far described can be usefully used to obtain an anti-microbial effect,
resulting from a temperature variation in mesophilic bacteria as reported in the following Section 4.
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4. Anti-Microbial Effect of the Plasmonic Photothermal Heating of Gold Nanoparticles
As already said, anti-bacterial properties of NPs are extensively used in biology. In most cases,
the anti-microbial effect of NPs is due to their toxicity, which can be intrinsic (due to the NPs effect
directly: Ag or TiO2) or due to a coating effect (see Section 2). In addition, a new approach is possible,
in which no toxicity is involved. If we consider mesophilic bacteria, that grow at a moderate temperature
(typically between 20 ◦C and 45 ◦C) it is possible to use the thermo-plasmonic effect of MNPs as
an antibacterial mean, without triggering any toxic effect. In particular, the heating mechanism of MNPs,
described in Section 3, shows how the used metal, shape, structure and surrounding medium [60,61]
play the main role in the heating process.
The photothermal-driven approach has been used in [62] where gold nanorods have been exposed
to near-infrared radiation and a significant reduction in bacterial cell viability [62] has been observed.
It is shown that it was possible to selectively target and destroy a pathogenic Gram-negative bacterium,
Pseudomonas aeruginosa by using gold nanorods covalently linked to primary antibodies.
A similar bactericidal and antibiofilm activity of gold nanorods (AuNRs) against oral microorganisms,
obtained by using plasmonic photothermal therapy (PPTT), is reported in [63]. The efficacy of PPTT was
obtained by reaching a temperature as high as 67 ◦C.
A rapid photothermal bacterial inactivation technique has been developed by Santos [64],
by irradiating near-infrared (NIR) light onto bacterial cells (Escherichia coli, Bacillus subtilis,
Exiguobacterium sp. AT1B) deposited on surfaces coated with a dense, randomly distributed array of
nanoporous gold disks (NPGDs). With the use of cell viability tests and SEM imaging analysis, a complete
inactivation of the pathogenic bacteria is confirmed within∼25 s of irradiation of the NPGD substrate.
Gold nanocrosses [65], conjugated to secondary and primary antibodies, completely destroy
P. aeruginosa and its biofilms upon near-infrared electromagnetic irradiation for 5 min with
a λ = 800 nm laser at low power density (∼3.0 W cm−2). No bacterial activity has been detected
after 48 h post irradiation, indicating that the heat generated by the irradiated gold nanocrosses
attached to bacteria was effective in eliminating and preventing the re-growth of bacteria. Overall,
the conjugated gold nanocrosses allowed an effective photothermal ablation of multidrug-resistant
bacteria and their biofilms in a targeted, well localized region, with reduced nonspecific damage to
healthy tissue.
By using a LED emission [66] (λpeak = 850 nm) to irradiate gold nanorods, a 71% of the early
biofilm of bacteria elimination has been shown after 5 min of irradiation, a result that shows the
potential of this novel antibiofilm technique. All above studies demonstrate that plasmonic generated
heat of MNPs offers a novel way to eliminate bacterial biofilms. As a perspective, in future applications
this method could also be used to eliminate bacterial contamination during implant surgery or simply
could represent a way to obtain solar photothermal disinfection [67].
The possibility to change the wavelength of the plasmonic peak by changing size, shape, structure
or surrounding medium makes the photoheating of MNPs a very usefull tool for antibacterial activities
(see Section 3). Using equations reported in Section 3 it is possible to take into account if the bacteria
are immersed in a water solution (refractive index 1.33) or in a tissue (refractive indices from 1.35 to
1.55). For a nano-shell in a tissue with refractive index 1.55, calculations show a plasmonic peak shift
of about 30 nm with respect to the peak position in water and similarly for the peaks of a multi-shell,
while, for a nanorod in a tissue, the calculation provides a plasmonic peak shift of more then 100 nm
with respect to the peak position in water. This high sensitivity of rods to the surrounding medium is
experimentally reported in [68]. Looking at Figure 4 it appears evident that, if bacteria are in a tissue,
it is necessary to choose a structure whose plasmonic peak wavelength stands in the bio-window (from
626 nm to 1316 nm), so that the penetration depth results satisfactory. Then, the value of the peak
position allows to calculate the local temperature increase (see Section 3, Equation (4)). It is possible
to change the absorption (and then the temperature variation) by changing size of the MNPs or their
eccentricity (in nanorods) or the ratio between the shell rays in the multi shell (onion-like NPs). In all
these cases, it is possible to manage the temperature increase, locally induced around the MNPs.
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The desired temperature to completely destroy bacteria depends on the specific bacteria and on
the exposition time; in general, for mesophilic bacteria, it is possible to completely destroy bacteria
in the range 50–60 ◦C. It is worth pointing out that, since the reached photo induced temperature
depends on all the parameters previously cited (shape, structure, surrounding, . . . ) and on the NPs
density, each specific case requires an “ad hoc” solution.
Figure 4. Effective penetration depth in tissue Near-infrared window in biological tissue (626–1316 nm).
5. Discussion
In all previous works, where heat is used as an antimicrobial agent, there is no detailed analysis
of the intrinsic toxicity of MNPs and then the percentage of effects due to heat and toxicity remains
unknown. Thus, if we want to exclude effects of toxicity, in addition to a coating material that has no
toxic activity, it is necessary to properly choose the metal which MNPs are made of, their dimensions
and the plasmonic resonant wavelength, by properly choosing shape and/or structure. The main
requirement for biological applications is related to the possibility to work with a plasmonic resonant
wavelength falling in the bio window (where the human body is transparent) in order to reach all
MNPs injected in the body (see Figure 4); this imposes to have the plasmonic resonance in the IR region.
This is achievable by using gold nanorods [62,63,66], gold nanocrosses [65], gold nanodisk [64] or more
complicated structures like onion-like or nanomatryoshka [58] structures: in all of these differently
shaped MNPs it is possible to have a plasmonic resonance (and a following heating process) in the IR
region. From a theoretical point of view, it is possible to predict temperature variations around one
or more MNPs by means of analytical or numerical analysis. The model can be used to calculate the
optimal MNPs concentration needed to obtain the desired effect.
6. Conclusions
In conclusion, we have analyzed the phenomenon of the antibiotical resistence, arguing that
the problem of multidrug resistance is related not only to the indiscriminate widespread use and
abuse of antibiotic, but also to the intrinsic capacity of bacteria to survive in a hostile environment,
as a consequence of their genetic plasticity. In fact, in addition to chromosomal mutations, bacteria have
sophisticated mechanisms to acquire, transfer and spread resistance genes. We present a tracking shot of
possible solutions to this problem through a nanotechnology-driven approach, showing that metal NPs
can be used to obtain an antibacterial effect, both for their toxic action and for an induced photo-thermal
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action. We report that the intrinsic toxic action of Ag and TiO2 or the induced toxicity of a NPs coating
with ligands (such as ionic surfactants or antibiotics) are able to exert an antimicrobial activity. We also
show that, for mesophilic bacteria, a new approach is possible, in which no toxicity is involved. By using
the thermo-plasmonic effect of metal nanoparticles, it is possible to completely destroy bacteria and
their biofilms, preventing also their re-growth. Furthermore, it is possible to selectively target and
destroy bacteria covalently linking the MNPs to primary antibodies. The importance of MNP shape,
structure, metal which they are made of, as well as the nature of the surrounding medium, is reported
and analyzed. A usefully implemented theoretical model enables to design those MNPs that prove more
suitable to obtain the desired effect.
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